1st Quarter - Report — EDWARDS LIFESCIENCES, LLC for EDWARDS LIFESCIENCES LLC (2016)

Firm

EDWARDS LIFESCIENCES, LLC

Client

EDWARDS LIFESCIENCES LLC

Income

—

Expenses

$320,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Senate "Innovation for Healthier Americans" Initiative Policies promoting medical innovation Medical Device User Fees Postmarket Surveillance FDA Quality Problems

Lobbyist	Covered position, as disclosed
ELIZABETH RAYE KEGLER	—
BARRY ROBERT LIDEN	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Taxation/Internal Revenue Code TAX

Domestic Manufacturing Credit Federal Corporate Tax Rate Foreign Source Income Tax Deferral H.R. 1, Tax Reform Act of 2014 Innovation Promotion Act of 2015 (Patent/Innovation Box draft legislation) Repatriation Senate Finance Committee Tax Reform Process Tax Reform Taxation of Offshore Income Transfer Pricing

Lobbyist	Covered position, as disclosed
ELIZABETH RAYE KEGLER	—
BARRY ROBERT LIDEN	—

Contacted: SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (114th)

Medicare/Medicaid MMM

CMS Coverage Policies For Medical Devices Senate "Innovation for Healthier Americans" Initiative CMS Payment Policies for Medical Devices

Lobbyist	Covered position, as disclosed
ELIZABETH RAYE KEGLER	—
BARRY ROBERT LIDEN	—

Contacted: Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.